BrainChild Bio masterminds $116M series A for CAR-T's pivotal push in pediatric brain cancer
Fuente:
FierceBiotech
A startup spawned from Seattle Children’s Hospital has raised a $116 million series A to advance cell therapies for devastating childhood brain tumors.